Cas:5570-19-4 (2-Nitrophenyl)boronic acid manufacturer & supplier

We serve Chemical Name:(2-Nitrophenyl)boronic acid CAS:5570-19-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2-Nitrophenyl)boronic acid

Chemical Name:(2-Nitrophenyl)boronic acid
CAS.NO:5570-19-4
Synonyms:2-Borononitrobenzene;Boronic acid, B-(2-nitrophenyl)-;nitrophenylboronic acid;RARECHEM AH PB 0142;O-NITROPHENYLBORONIC ACID;2-nitrobenzeneboronic acid;(2-Nitrophenyl)boronic acid;MFCD00161358;2-Nitrophenylboronsaeure
Molecular Formula:C6H6BNO4
Molecular Weight:166.927
HS Code:2931900090

Physical and Chemical Properties:
Melting point:155-160ºC
Boiling point:374.8±44.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.574
PSA:86.28000
Exact Mass:167.038986
LogP:1.32

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-Borononitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Nitrophenylboronsaeure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Borononitrobenzene Use and application,O-NITROPHENYLBORONIC ACID technical grade,usp/ep/jp grade.


Related News: Another critically important benefit of biocatalytic processes is that they are far more eco-efficient than conventional methods. This is because enzymes, being originally derived from natural products, generally perform best under mild (often ambient) conditions. (2S)-Bicyclo[2.2.1]heptane-2-carboxylic acid manufacturers It now operates fourteen plants across four continents, including two in southern California it inherited from its $112 million acquisition of German plastic packaging firm Balda in 2016. 2-(3-ethoxycarbonylpiperidin-1-yl)-2-(4-methylsulfanylphenyl)acetic acid suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. 1-methyl-2,3-dihydro-1,5-benzodiazepine vendor & factory.